Schizophrenia is classified among the world’s top ten enduring disabilities. Hearing voices are a profound and distressing symptom, which have proven difficult to successfully treat. We plan to use the latest brain imaging techniques and genetic testing to develop the most comprehensive understanding of hearing for voices to date. These data are vital to the development of novel tailored treatment for patients who hear voices.
Impact Of Somatic Versus Dendritic Inhibition On Neuronal Output
Funder
National Health and Medical Research Council
Funding Amount
$1,047,686.00
Summary
The brain is made up of literally billions of neurons connected in complex networks. These neurons come in two primary flavors - excitatory and inhibitory - which work in balance. Too much excitation and the brain becomes epileptic, too much inhibitory and we go into a coma. This proposal focuses on the role of specific inhibitory cell types in regulating brain function, and has relevant to a range of neurological disorders from epilepsy, to schizophrenia to depression.
The Modulation Of Neuronal Activity By Inter-cortical Sensory Input
Funder
National Health and Medical Research Council
Funding Amount
$638,771.00
Summary
For any given behaviour, the brain must merge information from all different sensory systems to generate a coherent representation of the external world. How this is achieved is largely unknown and is the basis of this research proposal. Here, using cutting edge recording techniques, the activity of brain cells within the cortex will be measured during the activation of multiple sensory systems. This research will provide insight into therapeutic approaches to local brain damage.
Function And Physiological Role Of Inhibitory Circuits In The Amygdala
Funder
National Health and Medical Research Council
Funding Amount
$741,518.00
Summary
The amygdala is part of the brain that assigns emotional content to our sensory world and dysfunction of the amygdala is responsible for many anxiety-related disorders. Many anxiolytics, like valium, act on receptors in the amygdala. In this project we will study circuits in the amygdala that are modulated by anxiolytics. These studies will provide essential information in the understanding of anxiety disorders and help in developing drugs to treat these disorders.
Discovery And Characterisation Of Novel Tick Evasins As Inhibitors Of Chemokine-mediated Inflammation
Funder
National Health and Medical Research Council
Funding Amount
$654,847.00
Summary
An important aspect of inflammatory diseases is the migration of white blood cells into the affected tissues. This is controlled by a group of proteins called chemokines. Ticks, which live on mammalian hosts, produce proteins called evasins, which interact with host chemokines and thereby prevent inflammatory responses. This project will discover new tick evasins, study their chemokine interactions and investigate their ability to block inflammation in allergic asthma.
Discovery Of New Tuberculosis Drug Leads Targeting Cell Wall Biosynthesis
Funder
National Health and Medical Research Council
Funding Amount
$714,816.00
Summary
There is a desperate need for the development of new therapies for the treatment of TB due to widespread resistance of Mycobacterium tuberculosis, the causative agent of TB, to current therapies. The overall goal of this research project is to identify new TB drug leads through the development of structural analogues of bacterially-derived natural products called the sansanmycins that inhibit cell wall synthesis in Mycobacterium tuberculosis.
The Role Of Presynaptic Inhibition In Neuropathic Pain
Funder
National Health and Medical Research Council
Funding Amount
$466,045.00
Summary
Inhibitory nerve cells in the spinal cord are thought to play an important role in governing the interaction between painful and non-painful stimuli. Defects in this process underlie allodynia, an important symptom of neuropathic pain. We will use recent advances in genetic techniques (optogenetics) to manipulate and study how inhibitory nerve cells separate touch and pain signalling in the spinal cord of normal and neuropathic animals.
Regulation Of Cortical Excitability By GABAB Receptors
Funder
National Health and Medical Research Council
Funding Amount
$340,976.00
Summary
In the brain electrical activity either excites or inhibits nerve cells. Excitation is balanced by inhibition. If these two processes become unbalanced we can become unconscious or go into seizure. These extreme conditions emphasize the importance of the balance between excitation and inhibition in the brain. While there has been much work on the role of excitation, less is known about inhibition. In this project proposal we will investigate how inhibition regulates excitation in the cortex.
The Role Of The Orbitofrontal Cortex In Disorders Of Response Inhibition
Funder
National Health and Medical Research Council
Funding Amount
$515,488.00
Summary
We will investigate the role of the orbitofrontal cortex (OFC) in decision-making, particularly the effect of hyperactivity in the medial vs. ventrolateral orbitofrontal cortex on decision-making. Hyperactivity in these structures has been linked to obsessive compulsive disorder and, in line with the distinct functions of the different regions of OFC, we develop and test a novel hypothesis as to the psychological and neural bases of the obsessions and compulsions distinctive to that disorder.
Does IRAP Contribute To Alzheimer's Disease Pathology?
Funder
National Health and Medical Research Council
Funding Amount
$743,042.00
Summary
Alzheimer’s disease is a progressive brain disease which is results in memory loss and cell death. All currently prescribed drugs treat the memory loss but are unable to stop the deterioration of brain cells. We have developed a class of drugs that reverse memory loss. These drugs target a protein called insulin-regulated aminopeptidase, IRAP. We recently found that these drugs also reduce the disease pathology. This research proposal aims to investigate the role of IRAP in the initiation or pro ....Alzheimer’s disease is a progressive brain disease which is results in memory loss and cell death. All currently prescribed drugs treat the memory loss but are unable to stop the deterioration of brain cells. We have developed a class of drugs that reverse memory loss. These drugs target a protein called insulin-regulated aminopeptidase, IRAP. We recently found that these drugs also reduce the disease pathology. This research proposal aims to investigate the role of IRAP in the initiation or progression of Alzheimer’s disease pathology.Read moreRead less